Results 171 to 180 of about 7,658,149 (357)

CHRONIC AGRANULOCYTOSIS [PDF]

, 1949
E. B. Adams, L. J. Witts
openalex   +1 more source

Are chronic wounds, chronic infections? [PDF]

Journal of Wound Care, 2016
openaire   +3 more sources

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

THE TREATMENT OF CHRONIC PANCREATITIS BY PANCREATOSTOMY [PDF]

, 1911
GOETHE LINK
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Evaluation of US Food and Drug Administration-recommended abuse-potential questions in chronic pain patients without history of recreational opioid use: results and plan for research

Journal of Pain Research, 2018
Joseph A Boscarino,1 Carrie A Withey,1 Ryan J Dugan,1 Thomas Alfieri2 1Department of Epidemiology and Health Services Research, Geisinger Clinic, Danville, PA 17822, USA; 2Medical Affairs, Purdue Pharma, Stamford, CT 06901, USA Background: Existing ...
Boscarino JA, Withey CA, Dugan RJ, Alfieri T   +3 more
doaj  

The Pathological Changes in Chronic Bronchitis and Emphysema [PDF]

, 1958
Lynne Reid
openalex   +1 more source

Chronic Rejection [PDF]

Immunity, 2001
Libby, Peter, Pober, Jordan S.
openaire   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

CHRONIC DUODENAL ULCER* PROCEDURES AS DETERMINED BY THE OPERATIVE PATHOLOGY

, 1940
J. William Hinton, ROLAND L. MAIER
openalex   +2 more sources